ARTICLE | Clinical News
Recombinant lipase: Phase I/IIa started
July 5, 2010 7:00 AM UTC
The partners began a French Phase I/IIa trial to evaluate oral recombinant lipase in 12 patients. Protea licensed exclusive U.S. marketing rights to the product from Mayoly-Spindler in May 2009. ...